Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
Study NCT ID:
NCT05903118
Status:
COMPLETED
Last Update Posted:
2024-01-10
First Post:
2023-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults
Sponsor:
Argorna Pharmaceuticals Co., LTD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-19
Completion Date Type:
ACTUAL
First Submit Date:
2023-06-12
First Submit QC Date:
None
Study First Post Date:
2023-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-09
Last Update Post Date:
2024-01-10
Last Update Post Date Type:
ACTUAL